DANONE : UBS remains Buy after CMD
The group unveiled the next chapter of its strategy, targeting 3 to 5% organic growth and an operating margin rising faster than sales for the period 2025-28, objectives that are in line with expectations according to UBS.
"CMD presented the progress made under the Renew strategy and a structurally improved outlook", points out the broker, adding that a convincing earnings growth algorithm translates into an annual EPS expansion of 8.5%.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.
Go to the original article.
Contact us to request a correction